Skip to main content
News

News

News

News

News

News

Press Release Investments in Materiomics

13 November 2015

Chemelot Ventures BV, Limburg Business Development Fund BV (LBDF) and the current shareholders have decided to jointly invest €1.4 million in Materiomics BV, located at the Brightlands Maastricht Health Campus. This financing round will be used to develop prototypes of medical devices with a smart surface structure like stents, catheters, breast implants, teeth implants and artificial hips. The smart surface structures will be developed in close cooperation with research institute MERLN at Maastricht University, MUMC+ and industrial partners. The entire text of the press release can be found pdfhere.